You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

D2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial in Beijing (Vitamin D2, )

Recruiting
  • Healthy Volunteers
  • Vitamin D2
  • placebo
  • Beijing, Beijing, China
    Peking University Third Hospital
Dec 30, 2022

Gastric Cancer Trial in Shijiazhuang (Robot-assisted D2 distal gastrectomy)

Recruiting
  • Gastric Cancer
  • Robot-assisted D2 distal gastrectomy
  • Shijiazhuang, Hebei, China
    Fourth Affiliated Hospital of Hebei Medical University
Feb 5, 2023

Healthy Trial in Taipei (Pleurotus citrinopileatus after bio-optics (10 ug group), Pleurotus citrinopileatus after bio-optics

Completed
  • Healthy
  • Pleurotus citrinopileatus after bio-optics (10 ug group)
  • Pleurotus citrinopileatus after bio-optics (100 ug group)
  • Taipei, Taiwan
    Taipei Medical University
Jan 28, 2023

Blood Loss, Intensive Care, Anastomotic Leakage Trial in Alexandria (LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (intervention),

Not yet recruiting
  • Blood Loss
  • +5 more
  • LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (intervention)
  • +3 more
  • Alexandria, Egypt
    The surgical department of Medical Research Institute Hospital,
Sep 19, 2023

Factors Affecting Difficulty of Laparoscopic D2 Lymph Node

Completed
  • Surgery-Complications
  • Whether lymph node dissection is qualified or not
  • Fuzhou, Fujian, China
    Department of Gastric Surgery
Oct 15, 2022

Chronic Kidney Disease 5D, Secondary Hyperparathyroidism Due to Renal Causes, Vitamin D Deficiency Trial (High-dose vitamin D2

Recruiting
  • Chronic Kidney Disease 5D
  • +2 more
  • High-dose vitamin D2 softgels
  • +2 more
  • Xi'an, Shaanxi, China
    The First Affiliated Hospital of Xi 'an Jiaotong University
Jan 5, 2023

Recurrent DLBCL, Refractory Diffuse Large B-cell Lymphoma Trial in Tianjin (RC19D2 cell injection)

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-cell Lymphoma
  • RC19D2 cell injection
  • Tianjin, Tianjin, China
    Hematology Hospital of the Chinese Academy of Medical Sciences
Sep 14, 2023

Newly Diagnosed MGMT Unmethylated Glioblastoma Trial in Durham (D2C7-IT, 2141-V11)

Not yet recruiting
  • Newly Diagnosed MGMT Unmethylated Glioblastoma
  • Durham, North Carolina
    Duke University Medical Center
Feb 7, 2023

Dopamine D2/3 Receptor Availability, Cognitive Function, Methamphetamine Abuse Trial in Los Angeles (Varenicline, Placebo)

Enrolling by invitation
  • Dopamine D2/3 Receptor Availability
  • +2 more
  • Los Angeles, California
    University of California Los Angeles
Mar 2, 2022

D1 vs D2 Lymphadenectomy in Gastric Cancer

Completed
  • Gastric Cancer
  • Lymphadenectomy type
  • (no location specified)
Feb 22, 2022

Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,

Not yet recruiting
  • Insulin Resistance
  • +3 more
  • Insulin human
  • +11 more
  • New York, New York
    Columbia University Irving Medical Center
Nov 6, 2023

Insulin Resistance, Prediabetic State, Hyperinsulinemia Trial in New York (drug, other, dietary supplement, device)

Recruiting
  • Insulin Resistance
  • +4 more
  • Insulin human
  • +8 more
  • New York, New York
    Columbia University Irving Medical Center
Feb 2, 2023

Gastric Cancer Trial in Qingdao (Hyperthermic Intraperitoneal Chemotherapy (HIPEC))

Recruiting
  • Gastric Cancer
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
May 14, 2023

Dopamine Receptor Binding in Treatment Resistant Depression

Not yet recruiting
  • Treatment Resistant Depression
  • PET scans
  • (no location specified)
Nov 9, 2022

Stroke, Acute Brain Injury Trial in Kingston (Dynavision D2)

Not yet recruiting
  • Stroke
  • Acute Brain Injury
  • Dynavision D2
  • Kingston, Ontario, Canada
    Providence Care Hospital
Aug 16, 2022

Preoperative Immunonutrition in Laparoscopic Total D2

Completed
  • Gastric Cancer
  • +4 more
  • immunonutrition
  • (no location specified)
Feb 17, 2022

in Vitro Fertilization, Poor Responder Trial in Toronto (metoclopramide)

Withdrawn
  • in Vitro Fertilization
  • Poor Responder
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Apr 7, 2022

Healthy Trial in Stillwater (Modality - 3D-2D, Modality - 2D-3D, Modality - 2D-2D)

Recruiting
  • Healthy
  • Modality - 3D-2D
  • +2 more
  • Stillwater, Oklahoma
    Oklahoma State University
Jul 1, 2022

MSI-H, PD-1 Immunotherapy, Gastric Cancer Trial in Shanghai (SOX, XELOX, Observation)

Not yet recruiting
  • MSI-H
  • +3 more
  • Shanghai, China
    Dazhi Xu
Jul 20, 2022

Healthy Trial in Stillwater (Modality - 3D-2D, Modality - 2D-3D, Modality - 2D-2D)

Recruiting
  • Healthy
  • Modality - 3D-2D
  • +2 more
  • Stillwater, Oklahoma
    Oklahoma State University
Jun 29, 2022

Malignant Glioma, Brain Tumor, Recurrent Trial in Durham (D2C7-IT)

Active, not recruiting
  • Malignant Glioma
  • Brain Tumor, Recurrent
  • Durham, North Carolina
    Preston Robert Tisch Brain Tumor Center at Duke
Jul 12, 2022

Obstetric Trial in Tokat (practice on birth simulator)

Active, not recruiting
  • Obstetric
  • practice on birth simulator
  • Tokat, Turkey
    Health Research and Training Hospital of Tokat Gaziosmanpaşa Uni
Aug 11, 2023

Healthy Trial in Stillwater (Modality - 3D-2D, Modality - 2D-3D, Modality - 2D-2D)

Recruiting
  • Healthy
  • Modality - 3D-2D
  • +2 more
  • Stillwater, Oklahoma
    Oklahoma State University
May 31, 2022

Neurosciences Trial (Précurseur de la dopamine, antagoniste D2, PLACEBO)

Not yet recruiting
  • Neurosciences
  • Précurseur de la dopamine
  • +2 more
  • (no location specified)
Feb 1, 2023

TNBC - Triple-Negative Breast Cancer Trial (A1:SG with SHR3680, A2:SG, B1:SG with SHR1210)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • A1:SG with SHR3680
  • +7 more
  • (no location specified)
Jun 23, 2023